Results 131 to 140 of about 35,659,151 (163)

Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach. [PDF]

World J Nephrol
Jose A, Kamrul-Hasan ABM, Fernandez CJ, Pappachan JM.   +3 more
europepmc   +1 more source

Letter to the Editor: Enhancing renin-angiotensin-aldosterone system inhibitors utilization through patiromer adherence - real-world insights for nephrology practice. [PDF]

World J Nephrol
Feyissa GD.
europepmc   +1 more source

GLP-1 receptor agonists-a potential therapy for chronic kidney disease? [PDF]

Clin Sci (Lond)
Boeckhaus J, Sayer JA, Mabillard H.
europepmc   +1 more source

ABCA1 as a Gatekeeper of Pancreatic β-Cell Cholesterol Homeostasis: Links Between Lipoprotein Stress, Lipotoxicity, and Insulin Secretion. [PDF]

Nutrients
Fukunaga K, Kobayashi T, Saheki T, Yoshimura T, Jiang W, Zhang H, Ly R, Kumano M, Yamashita A, Imachi H, Murao K.   +10 more
europepmc   +1 more source

Erratum: [Corrigendum] Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway. [PDF]

Oncol Lett
Zhao T, He Q, Liu Z, Ding X, Zhou X, Wang A.   +5 more
europepmc   +1 more source

Estimating the Benefits of the Comprehensive Disease-modifying Pharmacological Treatment in Patients with Heart Failure. [PDF]

Card Fail Rev
Escobar C, Caravaca-Pérez P, Fernandez-Rodriguez JM, Gomez-Otero I, Lozano-Bahamonde A, Pérez-Cabeza AI, Pérez-Silvestre J, Rafols C, Saldaña-García J, Esteban-Fernández A.   +9 more
europepmc   +1 more source

Autoantibodies targeting G protein-coupled receptors and clinical outcome after ischemic stroke (PROSCIS-B). [PDF]

J Neurol
Miesenberger AS, Arlt FA, Koschützke L, Gebert P, Heidecke H, Schulze-Forster K, Catar RA, Moll G, Harms C, Kufner A, Liman T, Prüss H, Endres M, Sperber PS.   +13 more
europepmc   +1 more source

Progress in Synthesis and Pharmacology of Telmisartan. [PDF]

Chem Biodivers
Megha, Srivastava R, Singh R.
europepmc   +1 more source

Effects of esaxerenone add-on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study. [PDF]

J Diabetes Investig
Ohara M, Omachi T, Takehana N, Fujikawa T, Osaka N, Irie S, Terasaki M, Mori Y, Matsui T, Yamagishi SI.   +9 more
europepmc   +1 more source

Thirst and blood pressure regulation in a novel angiotensin II receptor type 1a knockout rat. [PDF]

Physiol Rep
Ferreira CB, Stocker SD.
europepmc   +1 more source